Clinical Trial Enrichment in Systemic Sclerosis-Associated Interstitial Lung Disease: The Search Continues

Affiliations

¹ Division of Pulmonary and Critical Care, Department of Internal Medicine, University of Michigan, Ann Arbor, MI. Electronic address: wbonnie@med.umich.edu.
² Division of Pulmonary and Critical Care, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.

Editorial

Bonnie R Wang et al. Chest. 2023 Mar.

. 2023 Mar;163(3):475-476.

doi: 10.1016/j.chest.2022.11.001.

¹ Division of Pulmonary and Critical Care, Department of Internal Medicine, University of Michigan, Ann Arbor, MI. Electronic address: wbonnie@med.umich.edu.
² Division of Pulmonary and Critical Care, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.

No abstract available

Comment on

Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research.
Hoffmann-Vold AM, Brunborg C, Airò P, Ananyeva LP, Czirják L, Guiducci S, Hachulla E, Li M, Mihai C, Riemekasten G, Sfikakis PP, Valentini G, Kowal-Bielecka O, Allanore Y, Distler O; EUSTAR collaborators. Hoffmann-Vold AM, et al. Chest. 2023 Mar;163(3):586-598. doi: 10.1016/j.chest.2022.09.044. Epub 2022 Oct 14. Chest. 2023. PMID: 36244404